FCA
TMO icon

FLC Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

FLC Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-366
Closed -$244K – 178
2021
Q4 		$244K Hold
366
– – 0.07% 153
2021
Q3 		$209K Buy
+366
New +$201K 0.06% 166

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FLC Capital Advisors's TMO Position: Q1 2022 in Review

FLC Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 366 shares — an estimated $244K sold.

FLC Capital Advisors first reported a position in TMO in Q3 2021 and held it in 2 quarters. The position peaked at $244K in Q4 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

  • FLC Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
  • FLC Capital Advisors sold 366 Thermo Fisher Scientific shares in Q1 2022, an estimated $244K.
  • FLC Capital Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 2 quarters.
  • FLC Capital Advisors's Thermo Fisher Scientific position peaked at $244K in Q4 2021.
  • 2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on FLC Capital Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.